Upregulation of CALD1 predicted a poor prognosis for platinum-treated ovarian cancer and revealed it as a potential therapeutic resistance target
Ovarian cancer (OC) has the worst prognosis among gynecological malignancies, most of which are found to be in advanced stage. Cell reduction surgery based on platinum-based chemotherapy is the current standar...
Source: BMC Genomics - Category: Genetics & Stem Cells Authors: Wei Li, Limei Huang, Nana Qi, Qinle Zhang and Zailong Qin Tags: Research Source Type: research